124 related articles for article (PubMed ID: 6194835)
1. Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia-B patients.
Thompson AR
Blood; 1983 Nov; 62(5):1027-34. PubMed ID: 6194835
[TBL] [Abstract][Full Text] [Related]
2. Studies on immunological assay of vitamin-K dependent factors. III. A double monoclonal immunoradiometric assay for factor IX antigen.
Mikami S; O'Brien DP; Mellars G; Goodall AH; Tuddenham EG
Br J Haematol; 1986 Mar; 62(3):513-24. PubMed ID: 3485443
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.
Bajaj SP; Rapaport SI; Maki SL
J Biol Chem; 1985 Sep; 260(21):11574-80. PubMed ID: 3930478
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to factor IX: characterization and use in immunoassays for factor IX.
Smith KJ; Ono K
Thromb Res; 1984 Jan; 33(2):211-24. PubMed ID: 6422579
[TBL] [Abstract][Full Text] [Related]
5. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
Thompson AR
J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
[TBL] [Abstract][Full Text] [Related]
6. Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.
Chen SH; Thompson AR; Zhang M; Scott CR
J Clin Invest; 1989 Jul; 84(1):113-8. PubMed ID: 2472424
[TBL] [Abstract][Full Text] [Related]
7. Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B.
Christophe OD; Lenting PJ; Cherel G; Boon-Spijker M; Lavergne JM; Boertjes R; Briquel ME; de Goede-Bolder A; Goudemand J; Gaillard S; d'Oiron R; Meyer D; Mertens K
Blood; 2001 Sep; 98(5):1416-23. PubMed ID: 11520790
[TBL] [Abstract][Full Text] [Related]
8. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.
Bray GL; Weinmann AF; Thompson AR
J Lab Clin Med; 1986 Mar; 107(3):269-78. PubMed ID: 3485164
[TBL] [Abstract][Full Text] [Related]
9. Alloantibodies in hemophilia B binding to multiple factor IX epitopes.
Thompson AR
Thromb Res; 1987 Apr; 46(1):169-74. PubMed ID: 2438804
[No Abstract] [Full Text] [Related]
10. Polymorphism of normal factor IX detected by mouse monoclonal antibodies.
Wallmark A; Ljung R; Nilsson IM; Holmberg L; Hedner U; Lindvall M; Sjögren HO
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3839-43. PubMed ID: 3873655
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX.
Holmberg L; Gustavii B; Cordesius E; Kristoffersson AC; Ljung R; Löfberg L; Strömberg P; Nilsson IM
Blood; 1980 Sep; 56(3):397-401. PubMed ID: 7407407
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of human factor IX inhibitor antibodies.
Takahashi I; Mizumo S; Kamiya T; Takamatsu J; Saito H
Br J Haematol; 1994 Sep; 88(1):166-73. PubMed ID: 7528527
[TBL] [Abstract][Full Text] [Related]
13. Cleavage and activation of human factor IX by serine proteases.
Enfield DL; Thompson AR
Blood; 1984 Oct; 64(4):821-31. PubMed ID: 6383497
[TBL] [Abstract][Full Text] [Related]
14. Mutations in hemophilia Bm occur at the Arg180-Val activation site or in the catalytic domain of factor IX.
Bertina RM; van der Linden IK; Mannucci PM; Reinalda-Poot HH; Cupers R; Poort SR; Reitsma PH
J Biol Chem; 1990 Jul; 265(19):10876-83. PubMed ID: 2162822
[TBL] [Abstract][Full Text] [Related]
15. Immunologic studies of factor IX (Christmas factor). II. Immunoradiometric assay of factor IX antigen.
Yang HC
Br J Haematol; 1978 Jun; 39(2):215-24. PubMed ID: 678474
[TBL] [Abstract][Full Text] [Related]
16. Immunoassays of factor IX antigen using monoclonal antibodies.
Yoshioka A; Giddings JC; Thomas JE; Fujimura Y; Bloom AL
Br J Haematol; 1985 Feb; 59(2):265-75. PubMed ID: 3970858
[TBL] [Abstract][Full Text] [Related]
17. Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site.
Usharani P; Warn-Cramer BJ; Kasper CK; Bajaj SP
J Clin Invest; 1985 Jan; 75(1):76-83. PubMed ID: 3965513
[TBL] [Abstract][Full Text] [Related]
18. [Immunoradiometric assay of factor IX antigen using monoclonal antibody and classification of hemophilia B].
Yoshioka A; Ohkubo Y; Nishino M; Sakai T; Sugimoto M; Nishimura T; Tanaka I; Fukui H
Rinsho Ketsueki; 1985 Feb; 26(2):159-65. PubMed ID: 4021109
[No Abstract] [Full Text] [Related]
19. Sensitive solid phase enzyme immunoassay for factor IX antigen and classification of hemophilia B.
Takamatsu J; Kamiya T; Ogata K; Sugihara T; Koie K; Kato K
Haemostasis; 1983; 13(1):9-16. PubMed ID: 6341181
[TBL] [Abstract][Full Text] [Related]
20. Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemophilia B and evidence of proteolysis.
Thompson AR
Blood; 1984 Oct; 64(4):867-74. PubMed ID: 6478059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
